Farmer, AndrewJones, LouiseNewhouse, NikkiKenning, CassandraWilliams, NicolaChi, YuanBartlett, Y. KieraPlumpton, CatrinMcSharry, JennyCholerton, RachelHolmes, EmilyRobinson, StephanieAllen, JulieGudgin, BernardVelardo, CarmeloRutter, HeatherHorne, RobTarassenko, LionelWilliams, VeronikaLocock, LouiseRea, RustamYu, Ly MeeHughes, DyfrigBower, PeterFrench, David2022-04-122022-04-122022-02-21Farmer, A, Jones, L, Newhouse, N, Kenning, C, Williams, N, Chi, Y, Bartlett, Y K, Plumpton, C, McSharry, J, Cholerton, R, Holmes, E, Robinson, S, Allen, J, Gudgin, B, Velardo, C, Rutter, H, Horne, R, Tarassenko, L, Williams, V, Locock, L, Rea, R, Yu, L M, Hughes, D, Bower, P & French, D 2022, 'Supporting People With Type 2 Diabetes in the Effective Use of Their Medicine Through Mobile Health Technology Integrated With Clinical Care to Reduce Cardiovascular Risk : Protocol for an Effectiveness and Cost-effectiveness Randomized Controlled Trial', JMIR Research Protocols, vol. 11, no. 2, e32918. https://doi.org/10.2196/32918ORCID: /0000-0002-8109-1930/work/111385292https://hdl.handle.net/2164/18389Funding Information: The Support Through Mobile Messaging and Digital Health Technology for Diabetes research team acknowledges the support of the National Institute for Health Research (NIHR) through the Clinical Research Networks. AF, LT, and RR have received support from the NIHR Oxford Biomedical Research Centre. RH received support from the NIHR Collaboration for Leadership in Applied Health Research and Care and North Thames at Bart's Health National Health Service (NHS) Trust. The views expressed are those of the authors and not necessarily those of the NHS, the NIHR, or the Department of Health. This paper presents independent research funded by the NIHR under its Program Grants for Applied Research as part of a wider program of work (RP-PG-1214-20003). The authors thank the personnel of the University of Oxford Primary Care and Vaccines Clinical Trials Collaborative for providing support in the conduct of the trial.12517433engSDG 3 - Good Health and Well-beingCardiovascular risk preventionDiabetesDigital healthMedication adherenceRandomized controlled trialSMS text messagesR Medicine (General)General MedicineNational Institute for Health Research (NIHR)RP-PG-1214-20003R1Journal article10.2196/32918http://www.scopus.com/inward/record.url?scp=85126094049&partnerID=8YFLogxK112